Jcovden

COVID-19 (SARS-CoV-2) Vaccine (recombinant adenovirus vector)

Approval Information

Brand NameJcovden

Generic NameCOVID-19 (SARS-CoV-2) Vaccine (recombinant adenovirus vector)

ApprovedJune 2022

TypeInitial Approval

Review Reports

English Review Report

PDF · 1.78 MB

Japanese Review Report (1)

PDF · 1.13 MB

Japanese Review Report (2)

PDF · 93.42 KB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database